查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888745

遗传疾病诊断市场规模、份额和趋势分析报告：按技术、通路、应用、产品、最终用途、地区和细分市场预测（2025-2033 年）

Genetic Disease Diagnostics Market Size, Share & Trends Analysis Report By Technology (NGS, PCR-based Testing), By Channel (Online, Offline), By Application, By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

遗传疾病诊断市场摘要

全球遗传疾病诊断市场预计在 2024 年达到 117.1 亿美元，预计到 2033 年将达到 578.3 亿美元。

预计从 2025 年到 2033 年，该市场将以 19.1% 的复合年增长率成长。市场成长的主要驱动力是技术进步、对个人化医疗日益增长的需求以及对新生儿筛检需求的增加。

由于携带者筛检、非侵入性产前检测 (NIPT) 和体外受精 (IVF) 相关基因分析技术的进步，产科基因检测正在经历重大变化。这些创新正在推动市场持续成长，尤其是在已开发经济体和新兴经济体。

药物基因组学检测在帮助临床医生为患者选择最有效的药物和合适的剂量方面正变得日益重要。分子病理学协会 (AMP) 正引领实验室间此类检测的标准化工作。 2022 年 8 月，AMP 发布了针对 NUDT15 和 TPMT 等基因的临床基因分型检测的设计和检验建议。这些指南将为实验室提供一组最低限度的等位基因，以识别可能存在硫嘌呤毒性风险增加的患者，有助于提高治疗的安全性和有效性。

新型检测方法的引入有望显着降低治疗成本，避免过度处方和过量用药，从而降低药品价格，同时减少因药物不良反应引起的併发症和住院风险，预计将对市场成长产生积极影响。例如，2025年10月，总部位于印度海得拉巴的AIG医院与GenepowerRx公司合作推出了一项药物基因组学检测，该检测可以帮助医生根据患者的基因组成来开立处方并製定治疗方案。

由于次世代定序(NGS) 技术的进步，全基因测序(WGS) 的成本已降至 100 美元以下。许多公司正在推出基于次世代定序(NGS)、全基因测序和先进晶片技术的新型检测方法，这些方法能够提供更高的准确性、覆盖范围和更快的检测速度。例如，CENTOGENE 公司推出了“CentoGenome Ultra-Fast”，这是一款全基因测序工具，可在五个工作天内完成遗传疾病的诊断。快速诊断和早期疗育有助于采取适当的治疗措施，从而改善患者预后，并减少急诊和加护病房的併发症。

儘管取得了这些进展，但高昂的检测成本可能成为开发中国家市场成长的障碍。价格从不到100美元到超过2000美元不等，取决于检测的复杂程度，需要采集多个家庭成员样本的检测费用更高。检测结果可能需要几週才能出来。在某些情况下，如果由医疗专业人员开立处方，医疗保险会涵盖这些检测，但不同保险公司和保单的承保范围差异很大。

目录

第一章调查方法和范围

第二章执行摘要

3. 遗传疾病诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 遗传疾病诊断市场分析工具
    • 波特分析
    • PESTEL 分析

第四章：遗传疾病诊断市场：依技术分類的估算与趋势分析

  • 按技术分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：技术展望
  • 市场规模、预测与趋势分析（2021-2033）
    • 次世代定序
    • 阵列技术
    • 基于PCR的检测
    • FISH
    • 其他的

第五章：遗传疾病诊断市场：按应用分類的估算与趋势分析

  • 按应用领域分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：按应用领域分類的展望
  • 市场规模、预测与趋势分析（2021-2033）
    • 祖籍/民族
    • 房产筛检
    • 遗传疾病带因者状态
    • 新生儿筛检
    • 健康与保健－倾向、风险与趋势

第六章：遗传疾病诊断市场：依产品分類的估算与趋势分析

  • 按产品分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：产品展望
  • 市场规模、预测与趋势分析（2021-2033）
    • 消耗品
    • 装置
    • 软体和服务

第七章：遗传疾病诊断市场：按通路分類的估算和趋势分析

  • 按通路分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：通路
  • 市场规模、预测与趋势分析（2021-2033）
    • 在线的
    • 离线

第八章：遗传疾病诊断市场：依最终用途分類的估算与趋势分析

  • 按最终用途分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：按最终用途分類的展望
  • 市场规模、预测与趋势分析（2021-2033）
    • 医院和诊所
    • 诊断检查室
    • 其他的

第九章：遗传疾病诊断市场：区域估算与趋势分析

  • 按地区分類的市场份额（2024 年和 2033 年）
  • 全球遗传疾病诊断市场：区域展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Key company market share analysis, 2024
    • 24 genetics
    • Circle DNA
    • TellmeGen
    • 23andme
    • AncestryDNA
    • MyDNA
    • Igenomix
    • Myriad Genetics, Inc
    • Illumina, Inc.
    • MyHeritage Ltd.
    • Everly Well.
    • VitaGen
    • Mapmygenome
    • Helix OpCo LLC
    • Color Genomics, Inc.
    • Amgen, Inc.
    • Beyond Nutrition Health and Wellness Services DMCC.
Product Code: GVR-4-68040-814-0

Genetic Disease Diagnostics Market Summary

The global genetic disease diagnostics market size was estimated at USD 11.71 billion in 2024 and is projected to reach USD 57.83 billion by 2033, growing at a CAGR of 19.1% from 2025 to 2033. The market is primarily driven by technological advancements, increasing demand for personalized medicine, and growing demand for newborn screening..

Genetic testing in maternity care is undergoing a major transformation, driven by advancements in carrier screening, non-invasive prenatal testing (NIPT), and IVF-related genetic analyses. These innovations are fueling consistent market growth, especially across both established and emerging economies.

Pharmacogenomics testing is increasingly vital in helping clinicians choose the most effective medications and appropriate dosages for patients. The Association for Molecular Pathology (AMP) has made strides toward standardizing these tests across laboratories. In August 2022, the AMP released recommendations for designing and validating clinical genotyping assays for genes like NUDT15 and TPMT. These guidelines provide a minimum set of alleles for laboratories to identify patients who may be at a higher risk of thiopurine toxicity, thereby improving treatment safety and efficacy.

The introduction of new tests that can considerably reduce treatment costs and help lower pharmaceutical expenses by preventing overprescription and excessive dosing, while also reducing the risk of complications and hospitalizations resulting from adverse drug reactions, is expected to impact market growth positively. For instance, in October 2025, AIG Hospitals, a Hyderabad (India) based hospital, in collaboration with GenepowerRx, launched a pharmacogenomics test that would help doctors to prescribe medicines or decide on a treatment plan based on the patient's genetic makeup.

Driven primarily by advancements in Next-Generation Sequencing (NGS) technology, WGS costs are falling toward the sub-USD 100 threshold. Many companies have launched new tests based on next-generation sequencing (NGS), whole-genome sequencing, and advanced array technologies, offering higher accuracy, coverage, and rapid results. For instance, CENTOGENE launched CentoGenome Ultra-Fast, a whole-genome sequencing tool for diagnosing genetic diseases in five business days. Rapid diagnosis and early intervention facilitate timely treatment, which in turn improves patient outcomes and reduces complications in emergency cases and the ICU.

Despite these advancements, the high cost of the test may impede market growth in developing countries. Depending on the test's complexity, costs can range from under $100 to over $2,000, with higher costs associated with tests that require multiple family samples. Results may also take weeks to arrive. In some instances, health insurance covers these tests when prescribed by a medical professional, but coverage varies widely across insurers and policies.

Global Genetic Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genetic disease diagnostics market report based on technology, application, product, channel, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Next Generation Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Ancestry & Ethnicity
  • Traits Screening
  • Genetic Disease Carrier Status
  • New Baby Screening
  • Health and Wellness-Predisposition/Risk/Tendency
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Equipment
  • Software & Services
  • Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Offline
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Product
    • 1.2.4. Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Product outlook
    • 2.2.4. Channel outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Genetic Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological Advancements in Diagnostic Testing
      • 3.2.1.2. Growing Burden of Chronic and Infection Diseases
      • 3.2.1.3. Rising Awareness and Demand for Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Required Skilled Labors
  • 3.3. Genetic Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Genetic Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Genetic Disease Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 4.4.1. Next-Generation Sequencing
      • 4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Array Technology
      • 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. PCR - Based Testing
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. FISH
      • 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Genetic Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Genetic Disease Diagnostics Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 5.4.1. Ancestry & Ethnicity
      • 5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 5.4.2. Traits Screening
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Genetic Disease Carrier Status
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. New Baby Screening
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Health and Wellness - Predisposition/ Risk/tendency
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Genetic Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 6.1. Product Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Genetic Disease Diagnostics Market by Product Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 6.4.1. Consumables
      • 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 6.4.2. Equipment
      • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Software & Services
      • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Genetic Disease Diagnostics Market: Channel Estimates & Trend Analysis

  • 7.1. Channel Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Genetic Disease Diagnostics Market by Channel Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 7.4.1. Online
      • 7.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.2. Offline
      • 7.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Genetic Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2024 & 2033
  • 8.2. Segment Dashboard
  • 8.3. Global Genetic Disease Diagnostics Market by End Use Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 8.4.1. Hospitals & Clinics
      • 8.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 8.4.2. Diagnostic Laboratories
      • 8.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Others
      • 8.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Genetic Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2024
    • 10.3.4. 24 genetics
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Circle DNA
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. TellmeGen
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. 23andme
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. AncestryDNA
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. MyDNA
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Igenomix
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Myriad Genetics, Inc
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Illumina, Inc.
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. MyHeritage Ltd.
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Everly Well.
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. VitaGen
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Mapmygenome
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Helix OpCo LLC
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Color Genomics, Inc.
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Amgen, Inc.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Product benchmarking
      • 10.3.19.4. Strategic initiatives
    • 10.3.20. Beyond Nutrition Health and Wellness Services DMCC.
      • 10.3.20.1. Company overview
      • 10.3.20.2. Financial performance
      • 10.3.20.3. Product benchmarking
      • 10.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4 Global Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 6 Global Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 7 Global Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 8 Global Genetic Disease Diagnostics Market, by Region, 2021 - 2033 (USD Million)
  • Table 9 North America Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 10 North America Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 11 North America Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 12 North America Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 North America Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 14 North America Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 17 U.S. Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 U.S. Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 19 U.S. Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Canada Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 21 Canada Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Canada Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Canada Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 24 Canada Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 27 Europe Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 29 Europe Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 30 Europe Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Germany Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 32 Germany Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 33 Germany Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 34 Germany Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 35 Germany Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 UK Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 38 UK Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 UK Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 40 UK Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 France Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 42 France Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 France Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 44 France Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 45 France Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Italy Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 47 Italy Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Italy Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Italy Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 50 Italy Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Spain Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 52 Spain Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Spain Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 54 Spain Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 55 Spain Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 56 Denmark Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57 Denmark Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 58 Denmark Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 60 Denmark Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Sweden Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62 Sweden Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 63 Sweden Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Sweden Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 65 Sweden Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Norway Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 67 Norway Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Norway Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 Norway Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 70 Norway Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 73 Asia Pacific Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 74 Asia Pacific Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77 China Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 China Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 79 China Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 China Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 81 China Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Japan Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 83 Japan Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 84 Japan Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Japan Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 86 Japan Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 India Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88 India Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 India Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 90 India Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 91 India Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 South Korea Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 93 South Korea Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 South Korea Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 95 South Korea Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 96 South Korea Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97 Australia Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 98 Australia Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 99 Australia Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 100 Australia Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 101 Australia Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 102 Thailand Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Thailand Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 104 Thailand Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 105 Thailand Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 106 Thailand Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 107 Latin America Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 108 Latin America Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 109 Latin America Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 110 Latin America Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 111 Latin America Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 112 Latin America Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Brazil Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 114 Brazil Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Brazil Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 116 Brazil Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 117 Brazil Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 118 Mexico Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 119 Mexico Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 120 Mexico Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 121 Mexico Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 122 Mexico Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 123 Argentina Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Argentina Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 125 Argentina Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 126 Argentina Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 127 Argentina Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa Genetic Disease Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 134 South Africa Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 135 South Africa Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 136 South Africa Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 137 South Africa Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 138 South Africa Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 144 UAE Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 145 UAE Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 146 UAE Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 147 UAE Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 148 UAE Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Genetic Disease Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Genetic Disease Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Genetic Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Genetic Disease Diagnostics Market, by Channel, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Genetic Disease Diagnostics Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Genetic Disease Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Genetic Disease Diagnostics Market, Technology Movement Analysis
  • Fig. 16 Global Genetic Disease Diagnostics Market, for Next Generation Sequencing, 2021 - 2033 (USD Million)
  • Fig. 17 Global Genetic Disease Diagnostics Market, for Array Technology, 2021 - 2033 (USD Million)
  • Fig. 18 Global Genetic Disease Diagnostics Market, for PCR-based Testing, 2021 - 2033 (USD Million)
  • Fig. 19 Global Genetic Disease Diagnostics Market, for FISH, 2021 - 2033 (USD Million)
  • Fig. 20 Global Genetic Disease Diagnostics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 Global Genetic Disease Diagnostics Market, Application Movement Analysis
  • Fig. 22 Global Genetic Disease Diagnostics Market, for Ancestry & Ethnicity, 2021 - 2033 (USD Million)
  • Fig. 23 Global Genetic Disease Diagnostics Market, for Traits Screening, 2021 - 2033 (USD Million)
  • Fig. 24 Global Genetic Disease Diagnostics Market, for Genetic Disease Carrier Status, 2021 - 2033 (USD Million)
  • Fig. 25 Global Genetic Disease Diagnostics Market, for New Baby Screening, 2021 - 2033 (USD Million)
  • Fig. 26 Global Genetic Disease Diagnostics Market, for Health and Wellness - Predisposition/Risk/ Tendency, 2021 - 2033 (USD Million)
  • Fig. 27 Global Genetic Disease Diagnostics Market, Product Movement Analysis
  • Fig. 28 Global Genetic Disease Diagnostics Market, for Consumables, Movement Analysis
  • Fig. 29 Global Genetic Disease Diagnostics Market, for Equipment, 2021 - 2033 (USD Million)
  • Fig. 30 Global Genetic Disease Diagnostics Market, for Software & Services, 2021 - 2033 (USD Million)
  • Fig. 31 Global Genetic Disease Diagnostics Market, Channel Movement Analysis
  • Fig. 32 Global Genetic Disease Diagnostics Market, for Online, 2021 - 2033 (USD Million)
  • Fig. 33 Global Genetic Disease Diagnostics Market, for Offline, 2021 - 2033 (USD Million)
  • Fig. 34 Global Genetic Disease Diagnostics Market, End Use Movement Analysis
  • Fig. 35 Global Genetic Disease Diagnostics Market, for Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 36 Global Genetic Disease Diagnostics Market, for Diagnostic Laboratories, 2021 - 2033 (USD Million)
  • Fig. 37 Global Genetic Disease Diagnostics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 Regional Outlook, 2024 & 2033
  • Fig. 40 Global Genetic Disease Diagnostics Market, Region Movement Analysis
  • Fig. 41 North America Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 46 UK Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East and Africa Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Genetic Disease Diagnostics Market, 2021 - 2033 (USD Million)